homocystine has been researched along with Diabetes Mellitus, Type 2 in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, JW; Cheng, YZ; Dai, Q; Li, JB; Shi, M; Wang, HX; Wang, YJ; Zhang, HM; Zhang, Y | 1 |
Bets, D; Borger van der Burg, B; Donker, AJ; Kooy, A; Lehert, P; Ogterop, JC; Stehouwer, CD; Wulffelé, MG | 1 |
Ciccarelli, L; Cicero, AF; D'Angelo, A; Derosa, G; Ferrari, I; Gaddi, A; Gravina, A; Piccinni, MN; Pricolo, F; Ragonesi, PD; Salvadeo, SA | 1 |
Anyaoku, V; Donovan, J; Elkeles, RS; Feher, MD; Flather, MD; Godsland, IF; Khan, M; Nugara, F; Richmond, W; Rubens, MB | 1 |
Abid, M; Abid, N; Chaaba, R; Hammami, M; Koubaa, N; Nakbi, A; Smaoui, M | 1 |
2 trial(s) available for homocystine and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Effects of short-term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Schedule; Female; Folic Acid; Homocystine; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Vitamin B 12 | 2003 |
Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled
Topics: Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glycated Hemoglobin; Homocystine; Humans; Hypoglycemic Agents; Lipoproteins; Male; Metabolic Syndrome; Middle Aged; Pioglitazone; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones | 2006 |
3 other study(ies) available for homocystine and Diabetes Mellitus, Type 2
Article | Year |
---|---|
[The relationship between plasma homocysteine levels and diabetic peripheral neuropathy].
Topics: Adult; Aged; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Female; Homocystine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Peripheral Nervous System Diseases; Risk Factors | 2011 |
Coronary calcification, homocysteine, C-reactive protein and the metabolic syndrome in Type 2 diabetes: the Prospective Evaluation of Diabetic Ischaemic Heart Disease by Coronary Tomography (PREDICT) Study.
Topics: Adult; C-Reactive Protein; Calcinosis; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Homocystine; Humans; Male; Metabolic Syndrome; Middle Aged; Myocardial Ischemia; Predictive Value of Tests; Prospective Studies; Risk Factors; Tomography, X-Ray Computed | 2006 |
Hyperhomocysteinemia and elevated ox-LDL in Tunisian type 2 diabetic patients: role of genetic and dietary factors.
Topics: Case-Control Studies; Diabetes Mellitus, Type 2; Female; Homocystine; Humans; Hyperhomocysteinemia; Lipoproteins, LDL; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multivariate Analysis; Polymorphism, Genetic; Risk Factors; Tunisia | 2007 |